A study led by the University of Michigan Cardiovascular Center shows being a woman may not increase your risk of dying from treatment for a severe heart attack.
U-M researchers and colleagues in the Michigan Cardiovascular Consortium found women who received treatment such as an angioplasty had higher unadjusted in-hospital heart attack deaths.
But these differences appear to be related to women's ages and additional health problems – not gender, says study lead author Elizabeth Jackson, M.D., M.P.H., an assistant professor of internal medicine at the U-M Health System and member of the Women's Heart Program.
"When we adjusted for factors such as age and co-morbidities like hypertension and diabetes, women had similar mortality rates at the time of the heart attack as men," says Jackson.
"But women still appear to be more likely to have a bleeding episode in the hospital that requires a transfusion or vascular complications," she says.
The five-year study published in the American Heart Journal showed that compared with men, women were older with more co-morbidities – a medical condition in addition to the primary disease – at the time of treatment.
Women account for about one-third of patients who undergo procedures such as percutaneous coronary interventions to clear the clogged arteries causing a heart attack.
Researchers examined the outcomes of 8,771 patients undergoing a procedure for an acute ST-elevation myocardial infarction, commonly known as a severe heart attack. Patients were part of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium registry, a physician-led quality improvement collaborative that is supported by Blue Cross Blue Shield of Michigan and Blue Care Network.
Previous investigations using other registries have found women had higher in-hospital mortality rates than men, but recent advancements in treatment changed how doctors care for these patients and the team wanted to re-investigate with more current data, says Jackson.
"Overall, there have been tremendous improvements in the care of both men and women who suffer a heart attack, but further research on everyday patients, such as those in the registry, is needed to be able to continue improving our level of care," says Jackson.
Cardiovascular disease kills nearly twice as many women in the United States than all types of cancer, including breast cancer, according to the American Heart Association.
February is American Heart Month and several initiatives – such as the American Heart Association's annual National Wear Red Day and the new "Make the Call, Don't Miss a Beat" campaign by the U.S. Department of Health and Human Services and its Office on Women's Health – aim to bring national attention to women's heart disease.
Also this month, the American Heart Association released its updated guidelines on preventing cardiovascular disease in women and Jackson served on an expert panel that reviewed research and recommended changes.
The Cardiovascular Consortium, called BMC2, is a collaborative network of physicians at 32 Michigan hospitals that perform percutaneous coronary intervention, such as angioplasty and stents to treat patients with coronary artery diseases.
The University of Michigan has been the coordinating center for the statewide BMC2 consortium since 1997.
Additional U-M authors: Dean E. Smith, Ph.D., M.P.H.; David Share, M.D.; Paul M. Grossman, M.D.; Hitinder S. Gurm, M.D.
Other authors: Mauro Moscucci, M.D., M.B.A., University of Miami; Simon Dixon, M.B.Ch.B., William Beaumont Hospital; Adam Greenbaum, M.D., Henry Ford Hospital
Journal reference: American Heart Journal, DOI:10.1016/j.ahj.2010.09.030
Funding: Blue Cross Blue Shield of Michigan
Disclosures: Hitinder S. Gurm receives salary support from Blue Cross Blue Shield of Michigan. David Share is employed part time by Blue Cross Blue Shield of Michigan. Mauro Moscucci has received salary support from the Blue Cross Blue Shield of Michigan. None of the authors have any conflicts relevant to this study.Resources:
Heather Guenther | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering